Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Radiation Injuries 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Glioma 1 Glioblastoma 1 Fatigue 1 Cytokine Release Syndrome 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 45 Radiotherapy 16 Carboplatin 15 Irinotecan 12 Carmustine 12 Bevacizumab 12 Filgrastim 10 Vincristine 9 Surgical Procedures, Operative 9 Magnetic Resonance Spectroscopy 9 Procarbazine 7 Peripheral Blood Stem Cell Transplantation 6 Imatinib Mesylate 6 Erlotinib Hydrochloride 6 temsirolimus 5 sargramostim 5 O(6)-benzylguanine 5 Lomustine 5 Flucytosine 5 Etoposide 5 Thiotepa 4 Sirolimus 4 Cyclophosphamide 4 aldesleukin 3 Thalidomide 3 Surveys and Questionnaires 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Polymerase Chain Reaction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Oligodendroglioma × Neuropsychological Tests × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡